IL6 and obesity disorder: Circulating levels of the intestinal inflammatory factors CCL5 and IL-6 as well as the IL-18/IL-18BP ratio were increased (P < 0.05) in patients with obesity with and without T2D (Fig. 1G–L) being also significantly associated with endotoxin levels.